Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
400 results:

  • 1. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/akt pathway.
    Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
    BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients.
    Wang N; Tan X; Cao S; Liu M
    Pathol Res Pract; 2024 Apr; 256():155270. PubMed ID: 38552564
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
    Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
    Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
    Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
    J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discriminative and prognostic significance of LINC00623 for lung adenocarcinoma.
    Lin Y; Dong C; Zhang J; Zhu Y
    Ann Biol Clin (Paris); 2024 Feb; 81(6):591-601. PubMed ID: 38391164
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. G protein-coupled estrogen receptor activates PI3K/akt/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis.
    Chen J; Zhao R; Wang Y; Xiao H; Lin W; Diao M; He S; Mei P; Liao Y
    Mol Med; 2024 Feb; 30(1):28. PubMed ID: 38383297
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Plin2 inhibits autophagy via activating akt/mTOR pathway in non-small cell lung cancer.
    Wang Y; Hu Y; Xu R; Jin X; Jiao W
    Exp Cell Res; 2024 Feb; 435(2):113955. PubMed ID: 38301990
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote lung Squamous cell Carcinoma Malignancy and Chemoresistance.
    Wang H; Zhang Y; Tian Y; Yang W; Wang Y; Hou H; Pan H; Pei S; Zhu H; Gu Z; Zhang Y; Dai D; Chen W; Zheng M; Luo Q; Xiao Y; Huang J
    Cancer Res; 2024 Mar; 84(5):688-702. PubMed ID: 38199791
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Schwann cell-derived exosomes promote lung cancer progression via miRNA-21-5p.
    Zhou Y; Zhang Y; Xu J; Wang Y; Yang Y; Wang W; Gu A; Han B; Shurin GV; Zhong R; Shurin MR; Zhong H
    Glia; 2024 Apr; 72(4):692-707. PubMed ID: 38192185
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in lung cancer.
    Geng P; Zhao J; Li Q; Wang X; Qin W; Wang T; Shi X; Liu X; Chen J; Qiu H; Xu G
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069368
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature.
    Shemesh R; Laufer-Geva S; Gorzalczany Y; Anoze A; Sagi-Eisenberg R; Peled N; Roisman LC
    Sci Rep; 2023 Dec; 13(1):21544. PubMed ID: 38057448
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy.
    Alharthi NS; Al-Zahrani MH; Hazazi A; Alhuthali HM; Gharib AF; Alzahrani S; Altalhi W; Almalki WH; Khan FR
    Pathol Res Pract; 2024 Jan; 253():154998. PubMed ID: 38056133
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis.
    Kong F; Yang X; Lu Z; Liu Z; Yang Y; Wang Z
    PeerJ; 2023; 11():e16167. PubMed ID: 38047034
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-small cell lung cancer.
    Zhao H; Huang Y; Tong G; Wu W; Ren Y
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003378
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/akt signaling.
    Morel M; Long W
    Mol Oncol; 2024 Mar; 18(3):762-777. PubMed ID: 37983945
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
    Zhang S; Wang J; Zhang H
    Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
    Haratake N; Ozawa H; Morimoto Y; Yamashita N; Daimon T; Bhattacharya A; Wang K; Nakashoji A; Isozaki H; Shimokawa M; Kikutake C; Suyama M; Hashinokuchi A; Takada K; Takenaka T; Yoshizumi T; Mitsudomi T; Hata AN; Kufe D
    J Thorac Oncol; 2024 Mar; 19(3):434-450. PubMed ID: 37924972
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cisplatin-activated ERβ/DCAF8 positive feedback loop induces chemoresistance in non-small cell lung cancer via PTEN/akt axis.
    Hu Y; Xu Y; Zhang T; Han Q; Li L; Liu M; Li N; Shao G
    Drug Resist Updat; 2023 Nov; 71():101014. PubMed ID: 37913652
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Beyond the genome: lncRNAs as regulators of the PI3K/akt pathway in lung cancer.
    Almalki WH
    Pathol Res Pract; 2023 Nov; 251():154852. PubMed ID: 37837857
    [TBL] [Abstract] [Full Text] [Related]  


    of 20.